SNY
Sanofi
Ticker: SNYHealthcarePharmaceutical PreparationsHQ PARIS, I0CIK 1121404FY end 12-31
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- HQ
- PARIS, I0
- FY end
- 12-31
- CIK
- 1121404
- SIC
- 2834
Ownership
Who holds Sanofi — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VXUS · VANGUARD STAR FUNDS | 0.23% | $1.47B |
| VANGUARD DEVELOPED MARKETS INDEX FUND VEA · VANGUARD TAX-MANAGED FUNDS | 0.28% | $900.51M |
| Dodge & Cox Stock Fund DODGX · Dodge & Cox Funds | 0.75% | $891.79M |
| Bridge Builder International Equity Fund BBIEX · Bridge Builder Trust | 1.14% | $294.32M |
| VANGUARD EUROPEAN STOCK INDEX FUND VGK · VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.65% | $244.28M |
By share class
| Class | Held by funds | Funds | Shares out |
|---|---|---|---|
| SNY | — | 85 | — |
| SNYNF | — | 55 | — |
Bonds held by funds
Funds report holding 11 issues of Sanofi's debt, $637.08M at fund-held market value — what funds hold, not the company's debt outstanding. Weighted-average coupon 3.75%, maturing 2026–2038.
| Issue | Coupon | Matures | Funds | Fund-held |
|---|---|---|---|---|
| SANOFI SA | 4.210%Floating | 2028-11-03 | 12 | $142.79M |
| Sanofi SA | 4.130%Floating | 2027-11-03 | 15 | $125.02M |
| SANOFI SA | 4.200% | 2032-11-03 | 31 | $116.82M |
| SANFP 3.625 06/19/28 | 3.630% | 2028-06-19 | 43 | $100.17M |
| Sanofi SA | 3.800% | 2028-11-03 | 39 | $88.75M |
| SANFP 3.75 11/03/27 | 3.750% | 2027-11-03 | 27 | $50.84M |
| SANOFI 4(a)(2) CP 7/8/2026 | 0.000% | 2026-07-08 | 1 | $9.99M |
| Sanofi SA | 1.125% | 2028-04-05 | 1 | $1.11M |
| Sanofi, Series 12FX | 1.375% | 2030-03-21 | 1 | $0.77M |
| Sanofi, Series 20FX | 1.875% | 2038-03-21 | 1 | $0.48M |
The 10 largest by fund-held value, of 11.
Recent filingsView all →
No filings to show — refresh to retry if this looks wrong.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Read SNY's last four 10-Qs: what changed in segment trends, margins and management's narrative?
Run in your AI →Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of Sanofi's financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free